Takeda’s HYQVIA® Approved by European Commission as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] becomes the Only Facilitated Subcutaneous…

ENHERTU® Granted Priority Review in the U.S. for Patients with Metastatic HER2 Positive Solid Tumors

Application based on results from DESTINY-PanTumor02 trial and supported by additional ENHERTU data Submission to…

Wolters Kluwer launches AI-powered Lippincott Medical Education digital learning platform

Solution to deliver vital medical eBooks to universities and students across India in collaboration with…

REV3AL Announces Liquidity Locker Service Launch and Trust Wallet Listing Amidst Record Token Growth

NEVIS, SAINT KITTS AND NEVIS - News Direct - 29 January 2024 - REV3AL, a…

HeySara Goes On Acquisition Spree, Tops 2,000 Clients In Singapore

SINGAPORE - Media OutReach Newswire - 29 January 2024 - HeySara Pte. Ltd., a leading…

Dixon Technologies Selects Blue Yonder To Optimize Its Material and Capacity Planning

Leading Indian electronics manufacturer will improve planning efficiency, enhance planning accuracy and quality, and effectively…

Xapads Media Expands Business in China, Appoints Huang Xu as Country Head

~The global ad-tech platform is entering the region with its comprehensive digital marketing solutions~ BEIJING--(BUSINESS…

CORRECTING and REPLACING SoftBank Ventures Asia is Newly Becoming SBVA

The New SBVA Establishes KRW 200B ($150M) Korea Venture Fund SEOUL, South Korea--(BUSINESS WIRE)--Third paragraph…

Octa: The SEC’s approval of the bitcoin ETF will have a notable impact on investors

The U.S. Securities and Exchange Commission's (SEC) approval of the launch of 11 bitcoin exchange-traded…